Logo video2dn
  • Сохранить видео с ютуба
  • Категории
    • Музыка
    • Кино и Анимация
    • Автомобили
    • Животные
    • Спорт
    • Путешествия
    • Игры
    • Люди и Блоги
    • Юмор
    • Развлечения
    • Новости и Политика
    • Howto и Стиль
    • Diy своими руками
    • Образование
    • Наука и Технологии
    • Некоммерческие Организации
  • О сайте

Видео ютуба по тегу Volitionrx

VolitionRx Limited Third Quarter Results
VolitionRx Limited Third Quarter Results
Investing $25/Month in VOLITION RX $VNRX stocks since 2015? #stockmarket #trading #money
Investing $25/Month in VOLITION RX $VNRX stocks since 2015? #stockmarket #trading #money
VolitionRx Breaks Down Supply Agreement of Nu.Q® Vet Cancer Tests with IDEXX Laboratories
VolitionRx Breaks Down Supply Agreement of Nu.Q® Vet Cancer Tests with IDEXX Laboratories
VolitionRx 8-K: My Insight on This Underwriting Amendment
VolitionRx 8-K: My Insight on This Underwriting Amendment
VolitionRx (VNRX|$64.6M) - 2025 Q2 Earnings Analysis
VolitionRx (VNRX|$64.6M) - 2025 Q2 Earnings Analysis
VolitionRx Limited VNRX Q3 2025: колл-конференция по финансовым результатам
VolitionRx Limited VNRX Q3 2025: колл-конференция по финансовым результатам
VolitionRx's Report: My Take on Their
VolitionRx's Report: My Take on Their "Going Concern" Warning
Volition Signs First Human Out Licensing Deal
Volition Signs First Human Out Licensing Deal
VolitionRX VNRX Q2 2025 Earnings Call
VolitionRX VNRX Q2 2025 Earnings Call
VolitionRX
VolitionRX
VolitionRX GenomeWeb Webinar | Oct 08, 2025
VolitionRX GenomeWeb Webinar | Oct 08, 2025
VolitionRx: Blood tests for cancers
VolitionRx: Blood tests for cancers
VolitionRx - executive interview
VolitionRx - executive interview
VolitionRX Q2 2025 Earnings Call | Q2 2025 Earnings Conference Call | Q2 2025 Results
VolitionRX Q2 2025 Earnings Call | Q2 2025 Earnings Conference Call | Q2 2025 Results
VolitionRx - executive interview
VolitionRx - executive interview
VolitionRX chief delighted with first CE Mark in Europe
VolitionRX chief delighted with first CE Mark in Europe
VolitionRx First Quarter 2024 Financial Results and Business Update
VolitionRx First Quarter 2024 Financial Results and Business Update
VolitionRx - executive interview
VolitionRx - executive interview
Volition's Corporate Video
Volition's Corporate Video
Cameron Reynolds - Volition RX
Cameron Reynolds - Volition RX
VolitionRx developing a proprietary coronavirus triage test
VolitionRx developing a proprietary coronavirus triage test
VolitionRX (VNRX) - Cameron Reynolds, President & CEO
VolitionRX (VNRX) - Cameron Reynolds, President & CEO
Revolutionizing the Diagnosis of Life-altering Diseases - VolitionRx presents at GCFF June, 2022
Revolutionizing the Diagnosis of Life-altering Diseases - VolitionRx presents at GCFF June, 2022
🔴 VolitionRX Ltd VNRX Stock Trading Facts 🔴
🔴 VolitionRX Ltd VNRX Stock Trading Facts 🔴
Следующая страница»
  • О нас
  • Контакты
  • Отказ от ответственности - Disclaimer
  • Условия использования сайта - TOS
  • Политика конфиденциальности

video2dn Copyright © 2023 - 2025

Контакты для правообладателей [email protected]